Second Malignant Neoplasms Following Radiotherapy

Sanath Kumar
Additional contact information
Sanath Kumar: Department of Radiation Oncology, Henry Ford Hospital, Detroit MI 48202, USA

IJERPH, 2012, vol. 9, issue 12, 1-16

Abstract: More than half of all cancer patients receive radiotherapy as a part of their treatment. With the increasing number of long-term cancer survivors, there is a growing concern about the risk of radiation induced second malignant neoplasm [SMN]. This risk appears to be highest for survivors of childhood cancers. The exact mechanism and dose-response relationship for radiation induced malignancy is not well understood, however, there have been growing efforts to develop strategies for the prevention and mitigation of radiation induced cancers. This review article focuses on the incidence, etiology, and risk factors for SMN in various organs after radiotherapy.

Keywords: radiation; second malignancy; cancer therapy; side effects; radiotherapy; neoplasm (search for similar items in EconPapers)
JEL-codes: I I1 I3 Q Q5 (search for similar items in EconPapers)
Date: 2012
References: View complete reference list from CitEc
Citations:

Downloads: (external link)
https://www.mdpi.com/1660-4601/9/12/4744/pdf (application/pdf)
https://www.mdpi.com/1660-4601/9/12/4744/ (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:gam:jijerp:v:9:y:2012:i:12:p:4744-4759:d:22280

Access Statistics for this article

IJERPH is currently edited by Ms. Jenna Liu

More articles in IJERPH from MDPI
Bibliographic data for series maintained by MDPI Indexing Manager ().